Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALURNASDAQ:GEVONYSEAMERICAN:KULRNASDAQ:LUCD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$3.35+7.7%$4.01$2.15▼$98.75$16.06M-0.59712,016 shs491,998 shsGEVOGevo$1.23-1.6%$1.61$0.48▼$3.39$294.47M2.725.69 million shs2.47 million shsKULRKULR Technology Group$1.56-8.8%$2.00$0.20▼$5.49$426.74M2.3414.99 million shs8.93 million shsLUCDLucid Diagnostics$1.55$1.23$0.63▼$1.63$91.98M1.34361,367 shs783,872 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies-9.04%+31.37%-12.11%-67.99%-92.57%GEVOGevo-3.85%-8.09%-17.76%-17.22%+99.84%KULRKULR Technology Group0.00%+3.64%-9.52%-50.00%+718.18%LUCDLucid Diagnostics+3.33%+9.93%+6.16%+102.80%+46.23%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALURAllurion Technologies3.1256 of 5 stars3.55.00.00.02.31.70.6GEVOGevo1.6815 of 5 stars3.32.00.00.01.40.01.3KULRKULR Technology Group1.8967 of 5 stars3.52.00.00.01.90.80.6LUCDLucid Diagnostics2.2024 of 5 stars3.62.00.00.01.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 3.00Buy$22.83581.59% UpsideGEVOGevo 2.50Moderate Buy$8.63601.22% UpsideKULRKULR Technology Group 3.00Buy$5.00220.51% UpsideLUCDLucid Diagnostics 3.20Buy$3.40119.35% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, LUCD, KULR, and GEVO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/26/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.003/25/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.003/24/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $3.003/21/2025ALURAllurion TechnologiesRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.003/21/2025ALURAllurion TechnologiesChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.503/18/2025KULRKULR Technology GroupBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.00 ➝ $5.003/10/2025GEVOGevoHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.002/4/2025GEVOGevoHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.00(Data available from 3/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$34.75M0.46N/AN/A($36.95) per share-0.09GEVOGevo$15.59M18.89N/AN/A$2.32 per share0.53KULRKULR Technology Group$9.83M43.41N/AN/A($0.02) per share-78.00LUCDLucid Diagnostics$4.35M21.16N/AN/A($0.47) per share-3.30Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$80.61M-$12.00N/AN/AN/A-71.24%N/A-56.75%3/26/2025 (Estimated)GEVOGevo-$66.21M-$0.34N/AN/AN/A-510.04%-14.95%-12.69%4/30/2025 (Estimated)KULRKULR Technology Group-$23.69M-$0.12N/AN/AN/A-186.55%-751.30%-157.66%3/27/2025 (Estimated)LUCDLucid Diagnostics-$52.67M-$1.08N/AN/AN/A-1,069.87%N/A-123.54%5/12/2025 (Estimated)Latest ALUR, LUCD, KULR, and GEVO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/11/2025N/AKULRKULR Technology Group-$0.02N/AN/AN/A$2.87 millionN/A3/27/2025N/AKULRKULR Technology Group-$0.02N/AN/AN/A$2.87 millionN/A3/26/2025Q4 2024ALURAllurion Technologies-$5.00-$7.00-$2.00-$7.95$5.60 million$5.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AKULRKULR Technology GroupN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.332.09GEVOGevo0.138.258.05KULRKULR Technology Group0.050.810.71LUCDLucid DiagnosticsN/A1.181.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%GEVOGevo35.17%KULRKULR Technology Group21.23%LUCDLucid Diagnostics74.01%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%GEVOGevo4.00%KULRKULR Technology Group11.21%LUCDLucid Diagnostics8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5014.79 million2.01 millionOptionableGEVOGevo100239.41 million229.83 millionOptionableKULRKULR Technology Group60273.55 million242.89 millionNot OptionableLUCDLucid Diagnostics7059.34 million54.12 millionNo DataALUR, LUCD, KULR, and GEVO HeadlinesRecent News About These CompaniesLucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call TranscriptMarch 26 at 3:44 AM | seekingalpha.comLucid Diagnostics (NASDAQ:LUCD) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarch 26 at 1:59 AM | americanbankingnews.comLucid Diagnostics Earnings Call Highlights Growth and ChallengesMarch 25 at 8:15 PM | tipranks.comLucid Diagnostics (NASDAQ:LUCD) Given New $3.00 Price Target at Needham & Company LLCMarch 25 at 3:01 PM | marketbeat.comLucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Expectations By $0.06 EPSMarch 25 at 9:53 AM | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2024 Earnings Call TranscriptMarch 25 at 9:20 AM | insidermonkey.comLucid Diagnostics Reports Strong Growth and Future PlansMarch 25 at 12:24 AM | tipranks.comLucid Diagnostics reports Q4 EPS (19c) vs (23c) last yearMarch 24 at 11:29 PM | markets.businessinsider.comLucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Lags Revenue EstimatesMarch 24 at 10:10 AM | zacks.comComparing Beauty Health (NASDAQ:SKIN) & Lucid Diagnostics (NASDAQ:LUCD)March 24 at 1:53 AM | americanbankingnews.comLucid Diagnostics Inc (LUCD) Q4 2024 Earnings Report Preview: What To ExpectMarch 22, 2025 | finance.yahoo.comNeedham maintains Buy on Lucid Diagnostics, $2.50 targetMarch 22, 2025 | uk.investing.comLucid Diagnostics (LUCD) to Release Quarterly Earnings on MondayMarch 22, 2025 | americanbankingnews.comLucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer ScreeningMarch 20, 2025 | prnewswire.comBTIG Keeps Their Buy Rating on Lucid Diagnostics (LUCD)March 18, 2025 | markets.businessinsider.comLucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationMarch 18, 2025 | prnewswire.comLucid Diagnostics (LUCD) Expected to Announce Earnings on MondayMarch 17, 2025 | marketbeat.comShort Interest in Lucid Diagnostics Inc. (NASDAQ:LUCD) Rises By 72.1%March 16, 2025 | marketbeat.comLucid Diagnostics secures first positive insurance coverage for EsoGuard testMarch 13, 2025 | markets.businessinsider.comLucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA TestMarch 13, 2025 | prnewswire.comLucid Diagnostics (NASDAQ:LUCD) Trading Down 14.4% - Here's WhyMarch 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, LUCD, KULR, and GEVO Company DescriptionsAllurion Technologies NYSE:ALUR$3.35 +0.24 (+7.72%) Closing price 03:58 PM EasternExtended Trading$3.18 -0.17 (-5.07%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Gevo NASDAQ:GEVO$1.23 -0.02 (-1.60%) Closing price 04:00 PM EasternExtended Trading$1.25 +0.02 (+1.22%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.KULR Technology Group NYSEAMERICAN:KULR$1.56 -0.15 (-8.77%) Closing price 04:10 PM EasternExtended Trading$1.60 +0.03 (+2.24%) As of 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, develops and commercializes thermal management technologies for electronics, batteries, and other components applications in the United States. It provides lithium-ion battery thermal runaway shields; automated battery cell screening and test systems; cellchecks; safecases; fiber thermal interface materials; phase change material heat sinks; internal short circuit devices; and CRUX cathodes. The company's technologies are used in electric vehicles, energy storage, battery recycling transportation, cloud computing, and 5G communication devices. It sells its products for applications, such as lithium-ion battery energy storage, electric vehicles, 5G communication, cloud computer infrastructure, consumer, and industrial devices. The company was formerly known as KT High-Tech Marketing Inc. and changed its name to KULR Technology Group, Inc. in August 2018. KULR Technology Group, Inc. was founded in 2013 and is based in San Diego, California.Lucid Diagnostics NASDAQ:LUCD$1.55 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.50 -0.05 (-3.23%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Alphabet Too Cheap to Ignore After Its Recent Correction? Qualcomm Stock Is Coiling for a Breakout Tesla Stock: Has the Mother of All Comebacks Begun? Energy Transfer: Powering Data With Dividends and Diversification Advanced Micro Devices Can Double in Price: Here’s Why Palantir Setting Up to Be a Big Winner With New Defense Spending NVIDIA Insiders Sell: This Is What It Means for the Market Airship AI: Why This AI Penny Stock Is Poised for a Big Breakout Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
